Grifols SA (Germany) Performance
OZTA Stock | EUR 9.17 0.14 1.50% |
The company retains a Market Volatility (i.e., Beta) of -0.15, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Grifols SA are expected to decrease at a much lower rate. During the bear market, Grifols SA is likely to outperform the market. At this point, Grifols SA has a negative expected return of -0.061%. Please make sure to check out Grifols SA's jensen alpha, sortino ratio, and the relationship between the information ratio and total risk alpha , to decide if Grifols SA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Grifols SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Grifols SA is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow | 579.6 M | |
Total Cashflows From Investing Activities | -29.4 M |
Grifols |
Grifols SA Relative Risk vs. Return Landscape
If you would invest 971.00 in Grifols SA on December 17, 2024 and sell it today you would lose (54.00) from holding Grifols SA or give up 5.56% of portfolio value over 90 days. Grifols SA is producing return of less than zero assuming 2.6801% volatility of returns over the 90 days investment horizon. Simply put, 23% of all stocks have less volatile historical return distribution than Grifols SA, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Grifols SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Grifols SA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Grifols SA, and traders can use it to determine the average amount a Grifols SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0227
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | OZTA |
Estimated Market Risk
2.68 actual daily | 23 77% of assets are more volatile |
Expected Return
-0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Grifols SA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Grifols SA by adding Grifols SA to a well-diversified portfolio.
Grifols SA Fundamentals Growth
Grifols Stock prices reflect investors' perceptions of the future prospects and financial health of Grifols SA, and Grifols SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Grifols Stock performance.
Return On Equity | 0.0182 | |||
Return On Asset | 0.0155 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.09 % | |||
Current Valuation | 15.22 B | |||
Shares Outstanding | 422.18 M | |||
Price To Earning | 34.97 X | |||
Price To Book | 1.06 X | |||
Price To Sales | 1.22 X | |||
Revenue | 4.93 B | |||
EBITDA | 944.03 M | |||
Cash And Equivalents | 554.43 M | |||
Cash Per Share | 0.81 X | |||
Total Debt | 6.1 B | |||
Debt To Equity | 143.00 % | |||
Book Value Per Share | 9.32 X | |||
Cash Flow From Operations | 596.98 M | |||
Earnings Per Share | 0.09 X | |||
Total Asset | 19.23 B | |||
About Grifols SA Performance
By analyzing Grifols SA's fundamental ratios, stakeholders can gain valuable insights into Grifols SA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Grifols SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Grifols SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Grifols, S.A., a specialty pharmaceutical company, develops, manufactures, and distributes a range of biological medicines on plasma derived proteins worldwide. The company was founded in 1940 and is headquartered in Barcelona, Spain. GRIFOLS SA operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 22282 people.Things to note about Grifols SA performance evaluation
Checking the ongoing alerts about Grifols SA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Grifols SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Grifols SA generated a negative expected return over the last 90 days | |
Grifols SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
About 31.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Grifols SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Grifols SA's stock is overvalued or undervalued compared to its peers.
- Examining Grifols SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Grifols SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Grifols SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Grifols SA's stock. These opinions can provide insight into Grifols SA's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Grifols Stock analysis
When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |